ARKG Investment Tracker
Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.
0Follow
2699Followers
0Topic
0Badge
ARKG Investment Tracker position change: Decreased position in Veeva by 912 shares, the number of shares held decreased 2.22% compared to the previous period and now represents 0.74% of the total position.
ARKG Investment Tracker position change: Decreased position in Incyte by 3,078 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 1.08% of the total position.
ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 72,029 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 2.37% of the total position.
ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 50,293 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 5.65% of the total position.
ARKG Investment Tracker position change: Decreased position in Illumina by 9,424 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 4.48% of the total position.
ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 589 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 0.97% of the total position.
ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 36,138 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 2.46% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 264,233 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 4% of the total position.
ARKG Investment Tracker position change: Decreased position in Natera by 5,624 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 4.62% of the total position.
ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 113,164 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 1.58% of the total position.
ARKG Investment Tracker position change: Decreased position in Veracyte by 24,909 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 3.88% of the total position.
ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 11,229 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 3.18% of the total position.
ARKG Investment Tracker position change: Decreased position in Atai Beckley Inc by 74,898 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 1.14% of the total position.
ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 4,199 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 2.15% of the total position.
ARKG Investment Tracker position change: Decreased position in Amgen by 1,007 shares, the number of shares held decreased 2.23% compared to the previous period and now represents 1.21% of the total position.
ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 15,827 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 5.71% of the total position.
ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 50,806 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 4.91% of the total position.
ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 45,638 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 2.95% of the total position.
ARKG Investment Tracker position change: Decreased position in CareDx by 48,260 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 3.37% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 248,482 shares, the number of shares held decreased 2.26% compared to the previous period and now represents 1.81% of the total position.
Go to Tiger App to see more news